Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€127.00

€127.00

-0.160%
-0.2
-0.160%
€134.50

€134.50

 
12:53 / Tradegate WKN: 929138 / Symbol: A / Name: Agilent / Stock / Healthcare Equipment & Supplies / Large Cap /
Latest predictions
€135.15
26.08.24
0.84%
buy
€120.81
23.08.24
0.91%
€148.40
22.08.24
0.57%
buy
€144.00
22.08.24
0.17%
buy
€141.42
29.07.24
0.08%
buy
€138.51
10.07.24
8.84%
buy
Best running prediction
€118.76
21.11.23
15.10%
buy
Your prediction

Agilent Technologies Inc. Stock

The price for the Agilent Technologies Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.200 (-0.160%).
Currently there is a rather positive sentiment for Agilent Technologies Inc. with 16 Buy predictions and 5 Sell predictions.
As a result the target price of 134 € shows a slightly positive potential of 5.51% compared to the current price of 127.0 € for Agilent Technologies Inc..
Criterium "Business model" is seen as the biggest plus for Agilent Technologies Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Agilent Technologies is a leading global manufacturer of measuring instruments, software, services, and solutions for chemical analysis, life sciences, diagnostics, and electronic testing. The company provides a broad range of products from laboratory equipment to genetic testing tools and clinical diagnostics. Agilent's instruments are widely used in research laboratories, pharmaceutical companies, and government agencies, making it a significant player in the life sciences industry. The company operates in more than 100 countries and has a history of innovation, having developed some of the world's first portable gas chromatographs and UV-Vis spectrophotometers. Agilent's stock is traded on the New York Stock Exchange under the symbol "A."

Pros and Cons of Agilent Technologies Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Agilent Technologies Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Agilent Technologies Inc. -0.160% 3.247% 0.347% 20.970% 0.792% -14.228% 84.321%
Thermo Fisher Scientific Inc. -1.480% 0.180% 1.405% 16.691% 15.311% 9.237% 107.931%
QuidelOrtho Corp. 1.450% 2.451% 2.956% -41.060% -38.366% -68.018% -27.355%
Waters Corp. 1.170% 1.847% -1.206% 16.615% 0.397% -10.296% 46.793%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-14

Upon initial review, the financials of Agilent Technologies (US Symbol: A) from the Healthcare Equipment & Supplies industry appear to show steady growth and financial stability. The company has managed to increase its net income and total assets over the past few years, suggesting a strong and expanding financial position. This combined with a generally positive industry trend makes Agilent Technologies an interesting player in the healthcare equipment and supplies sector.

Pros

Revenue Growth: From 2020 to 2022, Agilent's total revenue increased from $5.34 billion to $6.85 billion, demonstrating consistent growth. This steady uptick in revenues suggests promising business prospects and an expanding market share in the industry.

Comments

Prediction Buy
Perf. (%) 0.84%
Target price 135.145
Change
Ends at 26.08.25

Agilent Technologies, Inc. (NYSE: A) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $151.00 price target on the stock.
Ratings data for A provided by MarketBeat
Show more

Prediction Sell
Perf. (%) 0.91%
Target price 120.812
Change
Ends at 23.08.25

Agilent Technologies, Inc. (NYSE: A) had its price target raised by analysts at Barclays PLC from $125.00 to $135.00. They now have an "underweight" rating on the stock.
Ratings data for A provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.57%
Target price 148.401
Change
Ends at 22.08.25

Agilent Technologies, Inc. (NYSE: A) had its price target raised by analysts at Citigroup Inc. from $150.00 to $165.00. They now have a "buy" rating on the stock.
Ratings data for A provided by MarketBeat
Show more

News

Agilent Completes Acquisition of BIOVECTRA: https://mms.businesswire.com/media/20240919413644/en/2248672/5/social-biovectra-sept-2024-b.jpg
Agilent Completes Acquisition of BIOVECTRA


Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO) that

Agilent Announces Cash Dividend of 23.6 Cents per Share:
Agilent Announces Cash Dividend of 23.6 Cents per Share


Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on Oct. 23, 2024, to all shareholders of record as of the close of

Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision MedicinePhoto, wide shot, wide-angle lens, soft focus,  Auto parts supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-XjwbnkgTrFCFx6Y3gLbqZBCj.png?st=2023-05-13T09%3A21%3A52Z&se=2023-05-13T11%3A21%3A52Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-13T06%3A55%3A39Z&ske=2023-05-14T06%3A55%3A39Z&sks=b&skv=2021-08-06&sig=wJlbn/o%2BieTjclaQNRsJc%2BDDZieC0UCS6BPi5tapxAA%3D
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine


Agilent Technologies Inc., (NYSE: A) today announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, following receipt of California State clinical laboratory